Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Immunology | Pulmonary/Respiratory Diseases | Vaccines | Infections and Infectious Diseases

Influenza Clinical Trials


A listing of Influenza medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

Arizona

Chandler : East Valley Family Physicians, PLC

Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived)

California

Beverly Hills : Updated

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Los Angeles : Updated

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

North Hollywood : Updated

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

San Diego : California Research Foundation

Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived)

San Francisco : Benchmark Research San Francisco

Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived)

Colorado

Denver : Updated

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Florida

Pinellas Park : Radiant Research - St. Petersburg

Clinical Research for Flu Vaccine

View More »

Coral Gables : Clinical Research of South Florida

Bifidobacterium Lactis HN019 Supplementation for Prevention of Influenza Infection in Healthy Adults

Coral Gables : Clinical Research of South Florida

Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived)

Debary : Updated

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Miami : Miami Research Associates

Safety and Immunogenicity of a Novel H5N1 Influenza Vaccine in Healthy Adults Age 18-49 Years

Tamarac : Updated

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Georgia

Columbus : Southeast Regional Research Group - Columbus

FLU Got You Blue? Ask NOW about a clinical research study that you may qualify for.

Savannah : Southeast Regional Research Group - Savannah

FLU Got You Blue? Ask NOW about a clinical research study that you may qualify for.

View More »

Stockbridge : Clinical Research Atlanta

Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived)

Illinois

Chicago : Updated

An Influenza Resistance Information Study (IRIS)

Kansas

Lenexa : Johnson County Clin-Trials

Safety and Immunogenicity of a Novel H5N1 Influenza Vaccine in Healthy Adults Age 18-49 Years

Overland Park : Quintiles Early Clinical Development

Assessment of CR6261, a Monoclonal Antibody Against the Influenza A Virus

Overland Park : Quintiles Early Clinical Development

Assessment of CR8020, a Monoclonal Antibody Against Influenza A Viruses

Wichita :

A Study of Intravenous Tamiflu (Oseltamivir) in Children With Influenza

Wichita : Heartland Research Associates, LLC

Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived)

Maryland

Baltimore : SNBL Clinical Pharmacology Center

Safety and Pharmacokinetics Study of Human Monoclonal Antibody (FGI-101-1A6)

Massachusetts

Brockton : Beacon Clinical Research

65+ Flu Vaccine Research Study

View More »

Boston :

A Pharmacokinetic/Pharmacodynamic Study of Tamiflu (Oseltamivir) in Immunocompromised Children With Confirmed Influenza Infection

Springfield : Updated

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Michigan

Detroit : Updated

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Rochester : Remedica, LLC

Bifidobacterium Lactis HN019 Supplementation for Prevention of Influenza Infection in Healthy Adults

Missouri

Kansas City : Dybedal Clinical Research Center

Influenza Study

View More »

Kansas City : The Center for Pharmaceutical Research, P.C.

Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived)

St. Louis : Updated

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

St. Louis : Sundance Clinical Research, LLC

Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived)

Nebraska

Omaha :

A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza

Omaha :

A Study of Intravenous Tamiflu (Oseltamivir) in Children With Influenza

New York

Rochester : Rochester Clinical Research

Elderly Flu Vaccine

View More »

Brooklyn :

A Study of Intravenous Tamiflu (Oseltamivir) in Children With Influenza

New York :

A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza

Rochester : Rochester Clinical Research Inc.

Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived)

Syracuse :

A Pharmacokinetic/Pharmacodynamic Study of Tamiflu (Oseltamivir) in Immunocompromised Children With Confirmed Influenza Infection

North Carolina

Cary : PMG Research of Cary, LLC

Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived)

Charlotte : Updated

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Durham : Updated

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

North Dakota

Bismarck : St. Alexius Medical Center

A study of an investigational medication for the treatment of the flu

Ohio

Cleveland : Rapid Medical Research, Inc.

Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived)

Toledo : Updated

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Oklahoma

Oregon

Eugene : Clinical Trials of America, Inc

Do you Currently Have the Flu?

Pennsylvania

Pittsburgh : Updated

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Pittsburgh : University of Pittsburgh, Division of Geriatric Medicine

Randomized Trial of High Dose Influenza Vaccine in Long Term Care Setting

South Carolina

Spartanburg : Spartanburg Medical Research

Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived)

Texas

Dallas : ACRC TRIALS

Dust Mite Allergy?

Dallas : ACRC TRIALS

Flu got you blue?

San Antonio : Sun Research Institute

Are you suffering from Flu-like symptoms?

San Antonio : Sun Research Institute

FLU got you blue?

View More »

Austin : Benchmark Research Austin

Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived)

Fort Worth : Benchmark Research

Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived)

Houston : Updated

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Utah

Salt Lake City : J. Lewis Research, Inc.

Flu Treatment

View More »

Salt Lake City : Jean Brown Research

Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived)

Australia

Brisbane : Capalaba Medical Centre

Validation of the Respirio Flu Test for the Rapid Identification of Influenza A/B

Brisbane : Taringa 7 Day Medical Practice

Validation of the Respirio Flu Test for the Rapid Identification of Influenza A/B

Westmead : Updated

An Influenza Resistance Information Study (IRIS)

Belgium

Bruxelles : Updated

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Leuven : Updated

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Bulgaria

Plovdiv : Updated

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Canada

Burlington : Aviva Medical Clinical Trials Group

Time to Oseltamivir Access When Prescribed by Pharmacists Versus Physicians (ACCESS)

Courtice : Co-Medica Research Network

Time to Oseltamivir Access When Prescribed by Pharmacists Versus Physicians (ACCESS)

Halifax : QEII Health Science Centre

Sentinel Surveillance for Influenza Requiring Hospital Admission Canadian Adults

Hamilton : McMaster

Sentinel Surveillance for Influenza Requiring Hospital Admission Canadian Adults

Kitchener : Dr. Sameh Fikry Medicine Professional Corporation

Time to Oseltamivir Access When Prescribed by Pharmacists Versus Physicians (ACCESS)

View More »

London : Schacter Medicine Professional Corporation

Time to Oseltamivir Access When Prescribed by Pharmacists Versus Physicians (ACCESS)

Mirabel : Omnispec Clinical Research Inc.

Time to Oseltamivir Access When Prescribed by Pharmacists Versus Physicians (ACCESS)

Montreal : MUCH

Sentinel Surveillance for Influenza Requiring Hospital Admission Canadian Adults

Montreal : Metropolitan Clinical Research Centre

Time to Oseltamivir Access When Prescribed by Pharmacists Versus Physicians (ACCESS)

Oshawa : Taunton Health Centre

Time to Oseltamivir Access When Prescribed by Pharmacists Versus Physicians (ACCESS)

Ottawa : Ottawa General

Sentinel Surveillance for Influenza Requiring Hospital Admission Canadian Adults

Pickering : Steeple Hill Medical Centre

Time to Oseltamivir Access When Prescribed by Pharmacists Versus Physicians (ACCESS)

Quebec : CHUl/CHUQ

Sentinel Surveillance for Influenza Requiring Hospital Admission Canadian Adults

Quebec : ALPHA Recherche Clinique

Time to Oseltamivir Access When Prescribed by Pharmacists Versus Physicians (ACCESS)

Saint John : Saint John Regional Hospital

Sentinel Surveillance for Influenza Requiring Hospital Admission Canadian Adults

Sarnia : London Road Diagnostic Clinic and Medical Centre

Time to Oseltamivir Access When Prescribed by Pharmacists Versus Physicians (ACCESS)

Sherbrooke : CHUS

Sentinel Surveillance for Influenza Requiring Hospital Admission Canadian Adults

St. John's : Paradise Medical Clinic

Time to Oseltamivir Access When Prescribed by Pharmacists Versus Physicians (ACCESS)

Strathroy : DCTM Clinical Trials Group Ltd.

Time to Oseltamivir Access When Prescribed by Pharmacists Versus Physicians (ACCESS)

Surrey : Fraser Health Authority

Adjuvanted Influenza Vaccine Effectiveness in the Elderly (65+Yrs)

Toronto : Mount Sinai Hospital

A Time-motion Study Comparing Self- to Nurse-vaccination With Influenza Vaccine

Toronto : Mount Sinai

Sentinel Surveillance for Influenza Requiring Hospital Admission Canadian Adults

Toronto : Dr. Anil Gupta

Time to Oseltamivir Access When Prescribed by Pharmacists Versus Physicians (ACCESS)

Vancouver : Vancouver General

Sentinel Surveillance for Influenza Requiring Hospital Admission Canadian Adults

China

Zhengzhou : Henan Center for Diseases Control and Prevention

The Immunogenicity and Safety of 2012-2013 Trivalent Seasonal Influenza Vaccine

Czech Republic

Parah 5 : Updated

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Tabor : Updated

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Terezin : Updated

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Zlin : Updated

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Estonia

Tallinn : Updated

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Tartu : Updated

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

France

Bron : Updated

An Influenza Resistance Information Study (IRIS)

Lyon : Updated

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Tours : Updated

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Germany

Berlin : Updated

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Berlin : Updated

An Influenza Resistance Information Study (IRIS)

Muenchen : Updated

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Hong Kong

Shatin : Updated

An Influenza Resistance Information Study (IRIS)

Hungary

Budapest : Updated

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Debrecen : Updated

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Gyor : Updated

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Gyula : Updated

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Pecs : Updated

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

View More »

Szekesfehervar : Updated

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Szolnok : Updated

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Veszprem : Updated

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Israel

Jerusalem : Hadassah medical center

A Study to Assess the Safety and Immunogenicity of an IM Influenza Vaccine (Multimeric-001) Followed by Administration of TIV to Elderly Volunteers

Petach Tikva : Updated

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Tel Hashomer : Updated

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Italy

Brescia : Updated

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Monza : Updated

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Roma : Updated

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Kenya

Kisumu : KEMRI/CDC- IEIP surveillance-Asembo

Seasonal Influenza Vaccine Effectiveness Study in Kenya

Nairobi : KEMRI/CDC IEIP surveillance- Kibera

Seasonal Influenza Vaccine Effectiveness Study in Kenya

Korea, Republic of

Incheon : GSK Investigational Site

Immunogenicity and Safety of PrepandrixTM in Korean Subjects Aged 18 to 60 Years Old

Latvia

Riga : Updated

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Lithuania

Kaunas : Updated

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Klaipeda : Updated

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Siauliai : Updated

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Vilnius : Updated

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Netherlands

Rotterdam : Updated

An Influenza Resistance Information Study (IRIS)

Poland

Bialystok : Updated

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Bydgoszcz : Updated

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Krakow : Updated

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Krakow : Updated

An Influenza Resistance Information Study (IRIS)

Lodz : Updated

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

View More »

Wroclaw : Updated

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Russian Federation

Saratov :

A Study of Arbidol (Umifenovir) for Treatment and Prophylaxis of Influenza and Common Cold

Spain

Madrid :

A Pharmacokinetic/Pharmacodynamic Study of Tamiflu (Oseltamivir) in Immunocompromised Children With Confirmed Influenza Infection

Madrid : Updated

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Taiwan

Taipei : National Taiwan University Hospital

A Trial to Assess the Immunogenicity and Safety of the Trivalent Virosomal Influenza Vaccine, Formulation of 2012-2013, in Non-Elderly Adults and Elderly Subjects

Taoyuan County : Chang Gung Memorial Hospital at Linkuo

A Trial to Assess the Immunogenicity and Safety of the Trivalent Virosomal Influenza Vaccine, Formulation of 2012-2013, in Healthy Subjects Aged Over 3 Years Old to 18 Years Old

United Kingdom

London :

Influenza Virus Challenge Study to Test Monoclonal Antibody TCN-032 as a Treatment for Influenza